tm logo

Monitor this mark

View On USPTO

AMPYRA
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 10 Jul 2021

Last Applicant/ Owned by

Acorda Therapeutics, Inc.

420 Saw Mill River Road

Ardsley

NY

10502

Serial Number

77948571 filed on 02th Mar 2010

Registration Number

4727839 registered on 28th Apr 2015

in the Principal Register

Correspondent Address

Joseph C. Guagliardo

Joseph C. Guagliardo Dentons US LLP

Chicago, IL 60604

UNITED STATES

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

AMPYRA

Pharmaceutical and biological preparations used in the treatment of spinal cord injuries, multiple sclerosis and other neurological disorders or conditions

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical and biological preparations used in the treatment of spinal cord injuries, multiple sclerosis and other neurological disorders or conditions

First Use Date in General

15th Feb 2012

First Use Date in Commerce

15th Feb 2012

Mark Details

Serial Number

No 77948571

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
28th Apr 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02th Dec 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02th Dec 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02th Dec 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02th Dec 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
02th Dec 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
10th Jul 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10th Jul 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10th Jul 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01st Mar 2021TEAS SECTION 8 & 15 RECEIVED